Viimeisin päivitys :
29/10/2024
Lääkkeiden stabiilius ja yhteensopivuus

Tervetuloa Stabilis-tietokantaan. Jos haluat saada neljästi vuodessa ilmestyvän tiedotuslehden, ilmoita sähköpostiosoitteesi.

Kirjaudu

Jos sinulla on jotain kysyttävää tai kommentteja, ole hyvä ja ota yhtey infostab@stabilis.org

Tietokannan  
Viitteet : 2788
Yhdiste : 868
Farmakologinen luokka : 46
Liuosten stabilius : 6405
Seosten stabilius : 1254
Yhteensopivuus : 12576
Kauppanimi : 5059
Uutiset - Yhdiste  
Antibiootit Salvat Clarithromycin 18/10/2024
Muut Silmätipat Methylprednisolone sodium succinate 08/07/2024
Muut Salvat Dutasteride 12/06/2024
Muut Salvat Clobetasol propiomate 12/06/2024
Vitamiinit Salvat Nicotinamide 12/06/2024
Muut Salvat Cafeine 04/06/2024
syöpälääke Injektioneste Pevonedistat 03/06/2024
Antibiootit Oraaliliuos Clofazimine 15/04/2024
Tulehduslääkkeet Salvat Diclofenac 08/04/2024
Muut Injektioneste Angiotensin II 02/04/2024
Muut Injektioneste Ranibizumab 08/03/2024
Muut Injektioneste Faricimab 08/03/2024
Muut Injektioneste Disodium glucose-1-phosphate tetrahydrate 18/01/2024
Viruslääkkeet Injektioneste Remdesivir 13/09/2023
Neuroleptit Oraaliliuos Lurasidone 28/08/2023
Muut Kapseli Cholic acid 12/06/2023
Muut Oraaliliuos L-Methionine 22/05/2023
Yleisanesteetit Peräpuikko Pentobarbital 22/05/2023
Antibiootit Kapseli Erythromycine 22/05/2023
Viruslääkkeet Silmätipat Ganciclovir 02/03/2023
Uutiset - Viitteet  
Saapumispäivä
4857 Physicochemical and Microbiological Stability of Compounded Clonidine Hydrochloride Oral iquid Dosage Forms in PCCA Base, SuspendIt®. Int J Pharm Compound 04/09/2024
4859 Physicochemical and Microbiological Stability of Compounded Bethanechol Chloride Oral Suspensions in PCCA Base, SuspendIt® Int J Pharm Compound 04/09/2024
4862 Erwinase, 10,000 IU/vial, Powder for solution for injection/infusion - Summary of Product Characteristics Updated 04-Jul-2022. Porton Biopharma Limited 04/09/2024
4852 KEYTRUDA 25 mg/mL solution à diluer pour perfusion. Résumé des caractéristiques du produit. Merck Sharp & Dohme B.V. 25/08/2024
4849 Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers? Pharmaceuticals 22/08/2024
4846 Chemical Stability of Lorazepam Oral Solution Repackaged in Plastic Oral Syringes at Room and Refrigerated Temperature. Hosp Pharm 03/07/2024
4843 Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration. Pharmaceutics 30/06/2024
4842 Harmonising IV Oxycodone with Paediatric Perioperative Medications: A Compatibility Study Through Y-Type Connectors Drug Design Dev Ther 28/06/2024
4837 Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 16/06/2024
4828 The Physical Compatibility of Glycopyrrolate and Rocuronium. Anesth Prog 15/06/2024
4831 Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr 15/06/2024
4832 Co‑administration of drugs with parenteral nutrition in the neonatal intensive care unit—physical compatibility between three components. Eur J Pedia 15/06/2024
4824 Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vials. EJHP 03/06/2024
4825 Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops. Farm Hosp 03/06/2024
4822 Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC Antimicrob Resist 08/05/2024
4821 AmBisome® Formulations for Pediatrics: Stability, Cytotoxicity, and Cost-Effectiveness Studies. Pharmaceutics 28/04/2024
4820 Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags. EJHP 17/04/2024
4819 Prolonging the stability of cetuximab (Erbitux®) and panitumumab (Vectibix®): An orthogonal assessment of physicochemical, biological and microbiological properties of original opened glass vials and diluted saline preparations. Int J Pharm 09/04/2024
4818 Giapreza 2.5mg per ml concentrate for solution for infusion - Summary of Product Characteristics Updated 30-Jun-2022 PAION UK Ltd 04/04/2024
4816 Stability Evaluation of Bracketed Diclofenac Sodium USP in VersaPro Cream Base, Versa Pro Gel Base and PLO Gel Mediflo30 Compound Kit. Int J Pharm Compound 26/03/2024
4813 Compatibility of Various Hormones in Phytobase and HRT Heavy Cream Bases Int J Pharm Compound 25/03/2024
4814 Compatiblity of Caffeine, Clobetasol Propionate, Dutasteride, Nicotinamide, and Progesterone in TrichoFoam, a Natural Vehicle for Hair Forms. Int J Pharm Compound 25/03/2024
4812 Stability of extemporaneously prepared clofazimine oral suspensions J Pharm Pract and Res 20/03/2024
4808 Characterizing the Stability of Angiotensin II in 0.9% Sodium Chloride Using High Performance Liquid Chromatography and Liquid Chromatography Tandem Mass Spectrometry. Hosp Pharm 06/03/2024
4807 Vectibix 20 mg/mL concentrate for solution for infusion. Summary of Product Characteristics Updated 13-Jul-2023 Amgen Ltd 21/02/2024
4801 Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 18/01/2024
4802 Glucose-1-Phosphate disodique tétrahydraté (Phocytan®) - Résumé des caractéristiques du produit Aguettant Laboratory 18/01/2024
4798 A silicone Oil-Free Syringe Tailored for Intravitreal Injection of Biologics. Frontiers in Ophthalmology 12/01/2024
4799 Stability of Voriconazole 10 mg/mL in IsoptoTears 0.5% stored in Glass Vials And Low Density Polyethylene Droppers at 4°C and 25°C for 28 Days. 12/01/2024
4800 Stability of Dr.Reddy’s Cabazitaxel Following Reconstitution with Manufacturer’s Diluent & Dilution with Sodium Chloride and Dextrose 5% in non-PVC non-DEHP bags and Original Glass Vials at 25°C, 4°C and -20°C. 12/01/2024

  Mentions Légales